These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3577984)

  • 21. Prospective evaluation of the use and outcome of admission stool guaiac testing: the Digital Rectal Examination on Admission to the Medical Service (DREAMS) Study.
    Bini EJ; Reinhold JP; Weinshel EH; Generoso R; Salman L; Dahr G; Pena-Sing I
    J Clin Gastroenterol; 2006 Oct; 40(9):821-7. PubMed ID: 17016139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Digital rectal fecal occult blood screening during gynecologic examination.
    Willis FL; Fanning J
    Am J Obstet Gynecol; 2004 May; 190(5):1422-3. PubMed ID: 15167856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digital fecal occult blood testing in the ambulatory urology clinic.
    Goetzl MA; Outman JE; Griebling TL; Holzbeierlein JM; Weigel JW; Thrasher JB
    J Am Coll Surg; 2008 Jan; 206(1):144-7. PubMed ID: 18155580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limitations of fecal occult blood testing.
    Sampliner RE
    Arch Intern Med; 1990 May; 150(5):945-6. PubMed ID: 2331199
    [No Abstract]   [Full Text] [Related]  

  • 25. Colorectal cancer screening by obstetrician-gynecologists.
    Musinski SE
    Am J Obstet Gynecol; 2001 May; 184(6):1054-6. PubMed ID: 11349154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
    Lohsiriwat V; Thavichaigarn P; Awapittaya B
    J Med Assoc Thai; 2007 Nov; 90(11):2291-5. PubMed ID: 18181309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
    El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
    Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of usefulness of faecal occult blood test. Prospective screening study in patients with colorectal neoplasia].
    Banaszkiewicz Z; Jawień A; Jarmocik P; Tojek K; Jankowski M; Switoński M
    Pol Merkur Lekarski; 2004 Dec; 17(102):579-82. PubMed ID: 15771126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Occult blood screening for colorectal cancer].
    Kumanishi Y; Fujita M; Taguchi T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2255-62. PubMed ID: 3729485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The law of unintended consequences: The Joint Commission regulations and the digital rectal examination.
    Adams BD; McHugh KJ; Bryson SA; Dabulewicz J
    Ann Emerg Med; 2008 Feb; 51(2):197-201, 201.e1. PubMed ID: 17961818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
    Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
    Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of upper gastrointestinal blood with fecal occult blood tests.
    Rockey DC; Auslander A; Greenberg PD
    Am J Gastroenterol; 1999 Feb; 94(2):344-50. PubMed ID: 10022627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical testing of occult blood in faeces: "haematest", "occultest", and guaiac testing correlated with chromium estimation of faecal blood loss.
    Humphery TJ; Goulston K
    Med J Aust; 1969 Jun; 1(25):1291-3. PubMed ID: 5797606
    [No Abstract]   [Full Text] [Related]  

  • 34. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.
    Greenberg PD; Bertario L; Gnauck R; Kronborg O; Hardcastle JD; Epstein MS; Sadowski D; Sudduth R; Zuckerman GR; Rockey DC
    Am J Gastroenterol; 2000 May; 95(5):1331-8. PubMed ID: 10811348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is dietary restriction always necessary in Haemoccult screening for colorectal neoplasia?
    Robinson MH; Thomas WM; Pye G; Hardcastle JD; Mangham CM
    Eur J Surg Oncol; 1993 Dec; 19(6):539-42. PubMed ID: 8270040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal occult blood: efficacy of testing measures.
    Hill SC
    Nurse Pract; 1980; 5(5):15, 17, 20-1. PubMed ID: 7432714
    [No Abstract]   [Full Text] [Related]  

  • 37. Colocare self-test versus Hemoccult II Sensa for fecal occult blood testing.
    Foliente RL; Wise GR; Collen MJ; Abdulian JD; Chen YK
    Am J Gastroenterol; 1995 Dec; 90(12):2160-3. PubMed ID: 8540507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrhea.
    Shastri YM; Bergis D; Povse N; Schäfer V; Shastri S; Weindel M; Ackermann H; Stein J
    Am J Med; 2008 Dec; 121(12):1099-106. PubMed ID: 19028207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal blood loss in patients with colonic polyps: a comparison of measurements with 51chromium-labeled erythrocytes and with the Haemoccult test.
    Herzog P; Holtermüller KH; Preiss J; Fischer J; Ewe K; Schreiber HJ; Berres M
    Gastroenterology; 1982 Nov; 83(5):957-62. PubMed ID: 7117808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for colorectal cancer. Use of a new protocol may reduce death rates.
    Lush DT
    Postgrad Med; 1994 Jul; 96(1):99-106. PubMed ID: 8022720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.